<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2020-08-12" version="193">
<accession>P47870</accession>
<accession>A8K115</accession>
<accession>A8K1A0</accession>
<accession>D1LYT0</accession>
<accession>D1LYT1</accession>
<accession>Q16323</accession>
<accession>Q4FZB2</accession>
<name>GBRB2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Gamma-aminobutyric acid receptor subunit beta-2</fullName>
</recommendedName>
<alternativeName>
<fullName>GABA(A) receptor subunit beta-2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">GABRB2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Mol. Pharmacol." volume="44" first="1211" last="1218">
<title>Role of the beta subunit in determining the pharmacology of human gamma-aminobutyric acid type A receptors.</title>
<authorList>
<person name="Hadingham K.L."/>
<person name="Wingrove P.B."/>
<person name="Wafford K.A."/>
<person name="Bain C."/>
<person name="Kemp J.A."/>
<person name="Palmer K.J."/>
<person name="Wilson A.W."/>
<person name="Wilcox A.S."/>
<person name="Sikela J.M."/>
<person name="Ragan C.I."/>
</authorList>
<dbReference type="PubMed" id="8264558"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Brain Res. Mol. Brain Res." volume="28" first="175" last="179">
<title>Cloning, sequence analysis and expression of two forms of mRNA coding for the human beta 2 subunit of the GABAA receptor.</title>
<authorList>
<person name="McKinley D.D."/>
<person name="Lennon D.J."/>
<person name="Carter D.B."/>
</authorList>
<dbReference type="PubMed" id="7707873"/>
<dbReference type="DOI" id="10.1016/0169-328x(94)00228-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E6977" last="E6977">
<title>Alternative-splicing in the exon-10 region of GABA(A) receptor beta(2) subunit gene: relationships between novel isoforms and psychotic disorders.</title>
<authorList>
<person name="Zhao C."/>
<person name="Xu Z."/>
<person name="Wang F."/>
<person name="Chen J."/>
<person name="Ng S.K."/>
<person name="Wong P.W."/>
<person name="Yu Z."/>
<person name="Pun F.W."/>
<person name="Ren L."/>
<person name="Lo W.S."/>
<person name="Tsang S.Y."/>
<person name="Xue H."/>
</authorList>
<dbReference type="PubMed" id="19763268"/>
<dbReference type="DOI" id="10.1371/journal.pone.0006977"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF THR-389</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ALTERNATIVE SPLICING</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Mol. Psychiatry" volume="11" first="1092" last="1105">
<title>Two isoforms of GABA(A) receptor beta2 subunit with different electrophysiological properties: Differential expression and genotypical correlations in schizophrenia.</title>
<authorList>
<person name="Zhao C."/>
<person name="Xu Z."/>
<person name="Chen J."/>
<person name="Yu Z."/>
<person name="Tong K.L."/>
<person name="Lo W.S."/>
<person name="Pun F.W."/>
<person name="Ng S.K."/>
<person name="Tsang S.Y."/>
<person name="Xue H."/>
</authorList>
<dbReference type="PubMed" id="16983389"/>
<dbReference type="DOI" id="10.1038/sj.mp.4001899"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2013" name="Eur. J. Neurosci." volume="38" first="3146" last="3158">
<title>GABA(A) receptors can initiate the formation of functional inhibitory GABAergic synapses.</title>
<authorList>
<person name="Fuchs C."/>
<person name="Abitbol K."/>
<person name="Burden J.J."/>
<person name="Mercer A."/>
<person name="Brown L."/>
<person name="Iball J."/>
<person name="Anne Stephenson F."/>
<person name="Thomson A.M."/>
<person name="Jovanovic J.N."/>
</authorList>
<dbReference type="PubMed" id="23909897"/>
<dbReference type="DOI" id="10.1111/ejn.12331"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2014" name="J. Vis. Exp." volume="2014" first="E52115" last="E52115">
<title>Inhibitory synapse formation in a co-culture model incorporating GABAergic medium spiny neurons and HEK293 cells stably expressing GABAA receptors.</title>
<authorList>
<person name="Brown L.E."/>
<person name="Fuchs C."/>
<person name="Nicholson M.W."/>
<person name="Stephenson F.A."/>
<person name="Thomson A.M."/>
<person name="Jovanovic J.N."/>
</authorList>
<dbReference type="PubMed" id="25489750"/>
<dbReference type="DOI" id="10.3791/52115"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10" evidence="1 2">
<citation type="journal article" date="2018" name="Nature" volume="559" first="67" last="72">
<title>Structure of a human synaptic GABAA receptor.</title>
<authorList>
<person name="Zhu S."/>
<person name="Noviello C.M."/>
<person name="Teng J."/>
<person name="Walsh R.M. Jr."/>
<person name="Kim J.J."/>
<person name="Hibbs R.E."/>
</authorList>
<dbReference type="PubMed" id="29950725"/>
<dbReference type="DOI" id="10.1038/s41586-018-0255-3"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY (3.80 ANGSTROMS) OF 25-331 IN COMPLEX WITH GABA AND FLUMAZENIL</scope>
<scope>FUNCTION</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2014" name="Am. J. Med. Genet. A" volume="164A" first="2914" last="2921">
<title>A novel variant in GABRB2 associated with intellectual disability and epilepsy.</title>
<authorList>
<person name="Srivastava S."/>
<person name="Cohen J."/>
<person name="Pevsner J."/>
<person name="Aradhya S."/>
<person name="McKnight D."/>
<person name="Butler E."/>
<person name="Johnston M."/>
<person name="Fatemi A."/>
</authorList>
<dbReference type="PubMed" id="25124326"/>
<dbReference type="DOI" id="10.1002/ajmg.a.36714"/>
</citation>
<scope>VARIANT IECEE2 THR-79</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2017" name="Am. J. Hum. Genet." volume="101" first="664" last="685">
<title>High rate of recurrent de novo mutations in developmental and epileptic encephalopathies.</title>
<authorList>
<consortium name="Deciphering Developmental Disorders Study"/>
<person name="Hamdan F.F."/>
<person name="Myers C.T."/>
<person name="Cossette P."/>
<person name="Lemay P."/>
<person name="Spiegelman D."/>
<person name="Laporte A.D."/>
<person name="Nassif C."/>
<person name="Diallo O."/>
<person name="Monlong J."/>
<person name="Cadieux-Dion M."/>
<person name="Dobrzeniecka S."/>
<person name="Meloche C."/>
<person name="Retterer K."/>
<person name="Cho M.T."/>
<person name="Rosenfeld J.A."/>
<person name="Bi W."/>
<person name="Massicotte C."/>
<person name="Miguet M."/>
<person name="Brunga L."/>
<person name="Regan B.M."/>
<person name="Mo K."/>
<person name="Tam C."/>
<person name="Schneider A."/>
<person name="Hollingsworth G."/>
<person name="FitzPatrick D.R."/>
<person name="Donaldson A."/>
<person name="Canham N."/>
<person name="Blair E."/>
<person name="Kerr B."/>
<person name="Fry A.E."/>
<person name="Thomas R.H."/>
<person name="Shelagh J."/>
<person name="Hurst J.A."/>
<person name="Brittain H."/>
<person name="Blyth M."/>
<person name="Lebel R.R."/>
<person name="Gerkes E.H."/>
<person name="Davis-Keppen L."/>
<person name="Stein Q."/>
<person name="Chung W.K."/>
<person name="Dorison S.J."/>
<person name="Benke P.J."/>
<person name="Fassi E."/>
<person name="Corsten-Janssen N."/>
<person name="Kamsteeg E.J."/>
<person name="Mau-Them F.T."/>
<person name="Bruel A.L."/>
<person name="Verloes A."/>
<person name="Ounap K."/>
<person name="Wojcik M.H."/>
<person name="Albert D.V.F."/>
<person name="Venkateswaran S."/>
<person name="Ware T."/>
<person name="Jones D."/>
<person name="Liu Y.C."/>
<person name="Mohammad S.S."/>
<person name="Bizargity P."/>
<person name="Bacino C.A."/>
<person name="Leuzzi V."/>
<person name="Martinelli S."/>
<person name="Dallapiccola B."/>
<person name="Tartaglia M."/>
<person name="Blumkin L."/>
<person name="Wierenga K.J."/>
<person name="Purcarin G."/>
<person name="O'Byrne J.J."/>
<person name="Stockler S."/>
<person name="Lehman A."/>
<person name="Keren B."/>
<person name="Nougues M.C."/>
<person name="Mignot C."/>
<person name="Auvin S."/>
<person name="Nava C."/>
<person name="Hiatt S.M."/>
<person name="Bebin M."/>
<person name="Shao Y."/>
<person name="Scaglia F."/>
<person name="Lalani S.R."/>
<person name="Frye R.E."/>
<person name="Jarjour I.T."/>
<person name="Jacques S."/>
<person name="Boucher R.M."/>
<person name="Riou E."/>
<person name="Srour M."/>
<person name="Carmant L."/>
<person name="Lortie A."/>
<person name="Major P."/>
<person name="Diadori P."/>
<person name="Dubeau F."/>
<person name="D'Anjou G."/>
<person name="Bourque G."/>
<person name="Berkovic S.F."/>
<person name="Sadleir L.G."/>
<person name="Campeau P.M."/>
<person name="Kibar Z."/>
<person name="Lafreniere R.G."/>
<person name="Girard S.L."/>
<person name="Mercimek-Mahmutoglu S."/>
<person name="Boelman C."/>
<person name="Rouleau G.A."/>
<person name="Scheffer I.E."/>
<person name="Mefford H.C."/>
<person name="Andrade D.M."/>
<person name="Rossignol E."/>
<person name="Minassian B.A."/>
<person name="Michaud J.L."/>
</authorList>
<dbReference type="PubMed" id="29100083"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2017.09.008"/>
</citation>
<scope>INVOLVEMENT IN IECEE2</scope>
<scope>VARIANTS IECEE2 THR-79; HIS-244; SER-277; LYS-284; PRO-293; ARG-303; VAL-304 AND ILE-316</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2017" name="J. Med. Genet." volume="54" first="202" last="211">
<title>A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy.</title>
<authorList>
<person name="Ishii A."/>
<person name="Kang J.Q."/>
<person name="Schornak C.C."/>
<person name="Hernandez C.C."/>
<person name="Shen W."/>
<person name="Watkins J.C."/>
<person name="Macdonald R.L."/>
<person name="Hirose S."/>
</authorList>
<dbReference type="PubMed" id="27789573"/>
<dbReference type="DOI" id="10.1136/jmedgenet-2016-104083"/>
</citation>
<scope>VARIANT IECEE2 PRO-287</scope>
<scope>CHARACTERIZATION OF VARIANT IECEE2 PRO-287</scope>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="5 6 9 10 12 13 15 16">Ligand-gated chloride channel which is a component of the heteropentameric receptor for GABA, the major inhibitory neurotransmitter in the brain (PubMed:8264558, PubMed:19763268, PubMed:27789573, PubMed:29950725). Plays an important role in the formation of functional inhibitory GABAergic synapses in addition to mediating synaptic inhibition as a GABA-gated ion channel (PubMed:23909897, PubMed:25489750). The gamma2 subunit is necessary but not sufficient for a rapid formation of active synaptic contacts and the synaptogenic effect of this subunit is influenced by the type of alpha and beta subunits present in the receptor pentamer (By similarity). The alpha1/beta2/gamma2 receptor and the alpha2/beta2/gamma2 receptor exhibit synaptogenic activity (PubMed:23909897, PubMed:25489750). Functions also as histamine receptor and mediates cellular responses to histamine (By similarity).</text>
</comment>
<comment type="activity regulation">
<text evidence="4 15">Allosterically activated by benzodiazepines (PubMed:29950725). Allosterically activated by the anesthetic etomidate (By similarity). Inhibited by the antagonist bicuculline (PubMed:29950725).</text>
</comment>
<comment type="subunit">
<text evidence="6 15 16">Heteropentamer, formed by a combination of alpha, beta, gamma, delta and rho chains (PubMed:8264558, PubMed:29950725). Interacts with UBQLN1 (By similarity). Interacts with KCTD8, KCTD12 and KCTD16; this interaction determines the pharmacology and kinetics of the receptor response, the KCTD proteins markedly accelerating the GABA-B response, although to different extents (By similarity). May interact with KIF21B (By similarity). Identified in a complex of 720 kDa composed of LHFPL4, NLGN2, GABRA1, GABRB2, GABRG2 and GABRB3 (By similarity).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="5">Cell junction</location>
<location evidence="5">Synapse</location>
<location evidence="5">Postsynaptic cell membrane</location>
<topology evidence="7">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="9 16">Cell membrane</location>
<topology evidence="7">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="6">Cytoplasmic vesicle membrane</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P47870-2</id>
<name>1</name>
<name>Long</name>
<name>Beta-2L</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P47870-1</id>
<name>2</name>
<name>Short</name>
<name>Beta-2S</name>
<sequence type="described" ref="VSP_038825"/>
</isoform>
<isoform>
<id>P47870-3</id>
<name>3</name>
<name>Beta-2S1</name>
<sequence type="described" ref="VSP_038823 VSP_038824 VSP_038828"/>
</isoform>
<isoform>
<id>P47870-4</id>
<name>4</name>
<name>Beta-2S2</name>
<sequence type="described" ref="VSP_038825 VSP_038826 VSP_038827"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="8 9">Isoform 1 and isoform 2 show reduced expression in schizophrenic brain. Isoform 3 shows increased expression in schizophrenic and bipolar disorder brains while isoform 4 shows reduced expression.</text>
</comment>
<comment type="domain">
<text evidence="5">The extracellular domain contributes to synaptic contact formation.</text>
</comment>
<comment type="PTM">
<text evidence="5">Glycosylated.</text>
</comment>
<comment type="disease" evidence="11 13 14">
<disease id="DI-05174">
<name>Epileptic encephalopathy, infantile or early childhood, 2</name>
<acronym>IECEE2</acronym>
<description>A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. IECEE2 is an autosomal dominant condition with variable age at seizure onset, ranging from early infancy to 6 years.</description>
<dbReference type="MIM" id="617829"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="22">Belongs to the ligand-gated ion channel (TC 1.A.9) family. Gamma-aminobutyric acid receptor (TC 1.A.9.5) subfamily. GABRB2 sub-subfamily.</text>
</comment>
<comment type="online information" name="Protein Spotlight">
<link uri="https://web.expasy.org/spotlight/back_issues/056"/>
<text>Forbidden fruit - Issue 56 of March 2005</text>
</comment>
<dbReference type="EMBL" id="S67368">
<property type="protein sequence ID" value="AAB29370.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S77554">
<property type="protein sequence ID" value="AAB33983.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S77553">
<property type="protein sequence ID" value="AAB33982.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="GU086163">
<property type="protein sequence ID" value="ACY69094.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="GU086164">
<property type="protein sequence ID" value="ACY69095.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK289730">
<property type="protein sequence ID" value="BAF82419.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK289815">
<property type="protein sequence ID" value="BAF82504.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471062">
<property type="protein sequence ID" value="EAW61543.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC099705">
<property type="protein sequence ID" value="AAH99705.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC099719">
<property type="protein sequence ID" value="AAH99719.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC105639">
<property type="protein sequence ID" value="AAI05640.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4354.1">
<molecule id="P47870-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4355.1">
<molecule id="P47870-2"/>
</dbReference>
<dbReference type="PIR" id="I52656">
<property type="entry name" value="I52656"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000804.1">
<molecule id="P47870-1"/>
<property type="nucleotide sequence ID" value="NM_000813.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_068711.1">
<molecule id="P47870-2"/>
<property type="nucleotide sequence ID" value="NM_021911.2"/>
</dbReference>
<dbReference type="PDB" id="6D6T">
<property type="method" value="EM"/>
<property type="resolution" value="3.80"/>
<property type="chains" value="A/C=25-331"/>
</dbReference>
<dbReference type="PDB" id="6D6U">
<property type="method" value="EM"/>
<property type="resolution" value="3.80"/>
<property type="chains" value="A/C=25-331"/>
</dbReference>
<dbReference type="PDBsum" id="6D6T"/>
<dbReference type="PDBsum" id="6D6U"/>
<dbReference type="SMR" id="P47870"/>
<dbReference type="BioGRID" id="108835">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2159">
<property type="entry name" value="GABA-A receptor, alpha-1/beta-2/gamma-2"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2952">
<property type="entry name" value="GABA-A receptor, alpha-6/beta-2/delta"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2953">
<property type="entry name" value="GABA-A receptor, alpha-4/beta-2/delta"/>
</dbReference>
<dbReference type="CORUM" id="P47870"/>
<dbReference type="IntAct" id="P47870">
<property type="interactions" value="4"/>
</dbReference>
<dbReference type="MINT" id="P47870"/>
<dbReference type="STRING" id="9606.ENSP00000274547"/>
<dbReference type="BindingDB" id="P47870"/>
<dbReference type="ChEMBL" id="CHEMBL1920"/>
<dbReference type="DrugBank" id="DB00659">
<property type="generic name" value="Acamprosate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00546">
<property type="generic name" value="Adinazolam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00404">
<property type="generic name" value="Alprazolam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00543">
<property type="generic name" value="Amoxapine"/>
</dbReference>
<dbReference type="DrugBank" id="DB11901">
<property type="generic name" value="Apalutamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB11859">
<property type="generic name" value="Brexanolone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01558">
<property type="generic name" value="Bromazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00237">
<property type="generic name" value="Butabarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB00241">
<property type="generic name" value="Butalbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB00395">
<property type="generic name" value="Carisoprodol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00475">
<property type="generic name" value="Chlordiazepoxide"/>
</dbReference>
<dbReference type="DrugBank" id="DB01594">
<property type="generic name" value="Cinolazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00349">
<property type="generic name" value="Clobazam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01068">
<property type="generic name" value="Clonazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00628">
<property type="generic name" value="Clorazepic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB01559">
<property type="generic name" value="Clotiazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01189">
<property type="generic name" value="Desflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB00829">
<property type="generic name" value="Diazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00228">
<property type="generic name" value="Enflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB01215">
<property type="generic name" value="Estazolam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00402">
<property type="generic name" value="Eszopiclone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00898">
<property type="generic name" value="Ethanol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00189">
<property type="generic name" value="Ethchlorvynol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00292">
<property type="generic name" value="Etomidate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01567">
<property type="generic name" value="Fludiazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01205">
<property type="generic name" value="Flumazenil"/>
</dbReference>
<dbReference type="DrugBank" id="DB00690">
<property type="generic name" value="Flurazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB06716">
<property type="generic name" value="Fospropofol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01381">
<property type="generic name" value="Ginkgo biloba"/>
</dbReference>
<dbReference type="DrugBank" id="DB01437">
<property type="generic name" value="Glutethimide"/>
</dbReference>
<dbReference type="DrugBank" id="DB00801">
<property type="generic name" value="Halazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01159">
<property type="generic name" value="Halothane"/>
</dbReference>
<dbReference type="DrugBank" id="DB00753">
<property type="generic name" value="Isoflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB00555">
<property type="generic name" value="Lamotrigine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00186">
<property type="generic name" value="Lorazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00603">
<property type="generic name" value="Medroxyprogesterone acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01043">
<property type="generic name" value="Memantine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00371">
<property type="generic name" value="Meprobamate"/>
</dbReference>
<dbReference type="DrugBank" id="DB00463">
<property type="generic name" value="Metharbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB01028">
<property type="generic name" value="Methoxyflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB01107">
<property type="generic name" value="Methyprylon"/>
</dbReference>
<dbReference type="DrugBank" id="DB01595">
<property type="generic name" value="Nitrazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00842">
<property type="generic name" value="Oxazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00312">
<property type="generic name" value="Pentobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB00252">
<property type="generic name" value="Phenytoin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01708">
<property type="generic name" value="Prasterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB01588">
<property type="generic name" value="Prazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB00794">
<property type="generic name" value="Primidone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00818">
<property type="generic name" value="Propofol"/>
</dbReference>
<dbReference type="DrugBank" id="DB01589">
<property type="generic name" value="Quazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB01236">
<property type="generic name" value="Sevoflurane"/>
</dbReference>
<dbReference type="DrugBank" id="DB09118">
<property type="generic name" value="Stiripentol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00306">
<property type="generic name" value="Talbutal"/>
</dbReference>
<dbReference type="DrugBank" id="DB01956">
<property type="generic name" value="Taurine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00231">
<property type="generic name" value="Temazepam"/>
</dbReference>
<dbReference type="DrugBank" id="DB11582">
<property type="generic name" value="Thiocolchicoside"/>
</dbReference>
<dbReference type="DrugBank" id="DB00897">
<property type="generic name" value="Triazolam"/>
</dbReference>
<dbReference type="DrugCentral" id="P47870"/>
<dbReference type="TCDB" id="1.A.9.5.2">
<property type="family name" value="the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family"/>
</dbReference>
<dbReference type="GlyGen" id="P47870">
<property type="glycosylation" value="3 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P47870"/>
<dbReference type="PhosphoSitePlus" id="P47870"/>
<dbReference type="BioMuta" id="GABRB2"/>
<dbReference type="DMDM" id="292495010"/>
<dbReference type="MassIVE" id="P47870"/>
<dbReference type="PaxDb" id="P47870"/>
<dbReference type="PeptideAtlas" id="P47870"/>
<dbReference type="PRIDE" id="P47870"/>
<dbReference type="ProteomicsDB" id="55801">
<molecule id="P47870-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55802">
<molecule id="P47870-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55803">
<molecule id="P47870-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55804">
<molecule id="P47870-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="4534">
<property type="antibodies" value="317 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000274547">
<molecule id="P47870-2"/>
<property type="protein sequence ID" value="ENSP00000274547"/>
<property type="gene ID" value="ENSG00000145864"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000353437">
<molecule id="P47870-1"/>
<property type="protein sequence ID" value="ENSP00000274546"/>
<property type="gene ID" value="ENSG00000145864"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000393959">
<molecule id="P47870-2"/>
<property type="protein sequence ID" value="ENSP00000377531"/>
<property type="gene ID" value="ENSG00000145864"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000520240">
<molecule id="P47870-1"/>
<property type="protein sequence ID" value="ENSP00000429320"/>
<property type="gene ID" value="ENSG00000145864"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000612710">
<molecule id="P47870-3"/>
<property type="protein sequence ID" value="ENSP00000480066"/>
<property type="gene ID" value="ENSG00000145864"/>
</dbReference>
<dbReference type="GeneID" id="2561"/>
<dbReference type="KEGG" id="hsa:2561"/>
<dbReference type="UCSC" id="uc003lyr.2">
<molecule id="P47870-2"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2561"/>
<dbReference type="DisGeNET" id="2561"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000145864.12"/>
<dbReference type="GeneCards" id="GABRB2"/>
<dbReference type="HGNC" id="HGNC:4082">
<property type="gene designation" value="GABRB2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000145864">
<property type="expression patterns" value="Tissue enriched (brain)"/>
</dbReference>
<dbReference type="MalaCards" id="GABRB2"/>
<dbReference type="MIM" id="600232">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="617829">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P47870"/>
<dbReference type="OpenTargets" id="ENSG00000145864"/>
<dbReference type="Orphanet" id="442835">
<property type="disease" value="Undetermined early-onset epileptic encephalopathy"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28496"/>
<dbReference type="eggNOG" id="KOG3643">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000154245"/>
<dbReference type="HOGENOM" id="CLU_010920_1_4_1"/>
<dbReference type="InParanoid" id="P47870"/>
<dbReference type="KO" id="K05181"/>
<dbReference type="OMA" id="RMDPNKM"/>
<dbReference type="OrthoDB" id="480926at2759"/>
<dbReference type="PhylomeDB" id="P47870"/>
<dbReference type="TreeFam" id="TF315453"/>
<dbReference type="PathwayCommons" id="P47870"/>
<dbReference type="Reactome" id="R-HSA-1236394">
<property type="pathway name" value="Signaling by ERBB4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-977443">
<property type="pathway name" value="GABA receptor activation"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="2561">
<property type="hits" value="2 hits in 870 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="GABRB2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="GABRB2"/>
<dbReference type="GenomeRNAi" id="2561"/>
<dbReference type="Pharos" id="P47870">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P47870"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 5"/>
</dbReference>
<dbReference type="RNAct" id="P47870">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000145864">
<property type="expression patterns" value="Expressed in primary visual cortex and 155 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P47870">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P47870">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0034707">
<property type="term" value="C:chloride channel complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0030659">
<property type="term" value="C:cytoplasmic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902711">
<property type="term" value="C:GABA-A receptor complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098982">
<property type="term" value="C:GABA-ergic synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0099060">
<property type="term" value="C:integral component of postsynaptic specialization membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045202">
<property type="term" value="C:synapse"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005254">
<property type="term" value="F:chloride channel activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004890">
<property type="term" value="F:GABA-A receptor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0022851">
<property type="term" value="F:GABA-gated chloride ion channel activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005237">
<property type="term" value="F:inhibitory extracellular ligand-gated ion channel activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030594">
<property type="term" value="F:neurotransmitter receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1904315">
<property type="term" value="F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071420">
<property type="term" value="P:cellular response to histamine"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007268">
<property type="term" value="P:chemical synaptic transmission"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1902476">
<property type="term" value="P:chloride transmembrane transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090102">
<property type="term" value="P:cochlea development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007214">
<property type="term" value="P:gamma-aminobutyric acid signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904862">
<property type="term" value="P:inhibitory synapse assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060119">
<property type="term" value="P:inner ear receptor cell development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060384">
<property type="term" value="P:innervation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034220">
<property type="term" value="P:ion transmembrane transport"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0043524">
<property type="term" value="P:negative regulation of neuron apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050877">
<property type="term" value="P:nervous system process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042391">
<property type="term" value="P:regulation of membrane potential"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007605">
<property type="term" value="P:sensory perception of sound"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051932">
<property type="term" value="P:synaptic transmission, GABAergic"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="2.70.170.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR006028">
<property type="entry name" value="GABAA/Glycine_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR002289">
<property type="entry name" value="GABAAb_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR006202">
<property type="entry name" value="Neur_chan_lig-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR036734">
<property type="entry name" value="Neur_chan_lig-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR006201">
<property type="entry name" value="Neur_channel"/>
</dbReference>
<dbReference type="InterPro" id="IPR036719">
<property type="entry name" value="Neuro-gated_channel_TM_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR006029">
<property type="entry name" value="Neurotrans-gated_channel_TM"/>
</dbReference>
<dbReference type="InterPro" id="IPR018000">
<property type="entry name" value="Neurotransmitter_ion_chnl_CS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR18945">
<property type="entry name" value="PTHR18945"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02931">
<property type="entry name" value="Neur_chan_LBD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02932">
<property type="entry name" value="Neur_chan_memb"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01160">
<property type="entry name" value="GABAARBETA"/>
</dbReference>
<dbReference type="PRINTS" id="PR00253">
<property type="entry name" value="GABAARECEPTR"/>
</dbReference>
<dbReference type="PRINTS" id="PR00252">
<property type="entry name" value="NRIONCHANNEL"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF63712">
<property type="entry name" value="SSF63712"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF90112">
<property type="entry name" value="SSF90112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00860">
<property type="entry name" value="LIC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00236">
<property type="entry name" value="NEUROTR_ION_CHANNEL"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0868">Chloride</keyword>
<keyword id="KW-0869">Chloride channel</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0407">Ion channel</keyword>
<keyword id="KW-0406">Ion transport</keyword>
<keyword id="KW-1071">Ligand-gated ion channel</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0628">Postsynaptic cell membrane</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0770">Synapse</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<feature type="signal peptide" evidence="3">
<location>
<begin position="1"/>
<end position="25"/>
</location>
</feature>
<feature type="chain" description="Gamma-aminobutyric acid receptor subunit beta-2" id="PRO_0000000459">
<location>
<begin position="26"/>
<end position="512"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="22">
<location>
<begin position="26"/>
<end position="244"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="22">
<location>
<begin position="245"/>
<end position="266"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="22">
<location>
<begin position="270"/>
<end position="292"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="22">
<location>
<begin position="304"/>
<end position="326"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="22">
<location>
<begin position="327"/>
<end position="489"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="22">
<location>
<begin position="490"/>
<end position="511"/>
</location>
</feature>
<feature type="region of interest" description="Agonist binding" evidence="3">
<location>
<begin position="119"/>
<end position="121"/>
</location>
</feature>
<feature type="region of interest" description="Agonist binding" evidence="3">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="region of interest" description="Allosteric effector binding" evidence="3">
<location>
<begin position="289"/>
<end position="310"/>
</location>
</feature>
<feature type="binding site" description="Agonist" evidence="3">
<location>
<position position="224"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="5">
<location>
<position position="441"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="32"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="104"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7">
<location>
<position position="173"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3">
<location>
<begin position="160"/>
<end position="174"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_038823" evidence="19">
<location>
<begin position="1"/>
<end position="63"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 4." id="VSP_038825" evidence="17 18 19 20 21">
<location>
<begin position="360"/>
<end position="397"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_038824" evidence="19">
<original>IFYKDIKQNGTQYRSLW</original>
<variation>VNSEGKPSLLLKLMEEC</variation>
<location>
<begin position="360"/>
<end position="376"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_038828" evidence="19">
<location>
<begin position="377"/>
<end position="512"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_038826" evidence="19">
<original>E</original>
<variation>D</variation>
<location>
<position position="410"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_038827" evidence="19">
<location>
<begin position="411"/>
<end position="512"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE2; unknown pathological significance; dbSNP:rs606231468." id="VAR_080712" evidence="11 14">
<original>M</original>
<variation>T</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE2; unknown pathological significance; dbSNP:rs1554094149." id="VAR_080713" evidence="14">
<original>Y</original>
<variation>H</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE2; unknown pathological significance; dbSNP:rs1554094145." id="VAR_080714" evidence="14">
<original>L</original>
<variation>S</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE2; unknown pathological significance." id="VAR_080715" evidence="14">
<original>T</original>
<variation>K</variation>
<location>
<position position="284"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE2; loss of localization to the cell membrane; retained intracellularly it affects the cell surface expression of the GABA receptor; decreased GABA receptor activity; dbSNP:rs1554093894." id="VAR_080716" evidence="13">
<original>T</original>
<variation>P</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE2; unknown pathological significance." id="VAR_080717" evidence="14">
<original>R</original>
<variation>P</variation>
<location>
<position position="293"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE2; unknown pathological significance; dbSNP:rs1554093885." id="VAR_080718" evidence="14">
<original>K</original>
<variation>R</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE2; unknown pathological significance." id="VAR_080719" evidence="14">
<original>A</original>
<variation>V</variation>
<location>
<position position="304"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE2; unknown pathological significance; dbSNP:rs1554093884." id="VAR_080720" evidence="14">
<original>V</original>
<variation>I</variation>
<location>
<position position="316"/>
</location>
</feature>
<feature type="mutagenesis site" description="Displays reduced current rundown following repeated receptor activation." evidence="9">
<original>T</original>
<variation>A</variation>
<location>
<position position="389"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; BAF82419." ref="4" evidence="22">
<original>Q</original>
<variation>L</variation>
<location>
<position position="336"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6D6T"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6D6U"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P0C2W5"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P63137"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P63138"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255"/>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16983389"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19763268"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23909897"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25124326"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25489750"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27789573"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29100083"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29950725"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8264558"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="19763268"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7707873"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8264558"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000305"/>
<sequence length="512" mass="59150" checksum="C390A0C92815DD89" modified="2010-03-23" version="2" precursor="true">MWRVRKRGYFGIWSFPLIIAAVCAQSVNDPSNMSLVKETVDRLLKGYDIRLRPDFGGPPVAVGMNIDIASIDMVSEVNMDYTLTMYFQQAWRDKRLSYNVIPLNLTLDNRVADQLWVPDTYFLNDKKSFVHGVTVKNRMIRLHPDGTVLYGLRITTTAACMMDLRRYPLDEQNCTLEIESYGYTTDDIEFYWRGDDNAVTGVTKIELPQFSIVDYKLITKKVVFSTGSYPRLSLSFKLKRNIGYFILQTYMPSILITILSWVSFWINYDASAARVALGITTVLTMTTINTHLRETLPKIPYVKAIDMYLMGCFVFVFMALLEYALVNYIFFGRGPQRQKKAAEKAASANNEKMRLDVNKIFYKDIKQNGTQYRSLWDPTGNLSPTRRTTNYDFSLYTMDPHENILLSTLEIKNEMATSEAVMGLGDPRSTMLAYDASSIQYRKAGLPRHSFGRNALERHVAQKKSRLRRRASQLKITIPDLTDVNAIDRWSRIFFPVVFSFFNIVYWLYYVN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

